Traveler's Diarrhea Therapeutics - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Traveler's Diarrhea Therapeutics - Global Top Players Market Share and Ranking 2025

Traveler's Diarrhea Therapeutics - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-04
Report Id: 2678596
Industry: Pharma & Healthcare
Report Page: 101
Chart: 110

PDF Download

Publication Date: 2025-11-04
Report Id: 2678596
Industry: Pharma & Healthcare
Report Page: 101
Chart: 110

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Traveler's Diarrhea Therapeutics Definition
1.2 Global Traveler's Diarrhea Therapeutics Market Size and Forecast
1.2.1 By Consumption Value, Global Traveler's Diarrhea Therapeutics Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Traveler's Diarrhea Therapeutics Market Size, 2020-2031
1.2.3 Global Traveler's Diarrhea Therapeutics Average Selling Price (ASP), 2020-2031
1.3 China Traveler's Diarrhea Therapeutics Market Size and Forecast
1.3.1 By Consumption Value, China Traveler's Diarrhea Therapeutics Market Size, 2020-2031
1.3.2 By Sales Quantity, China Traveler's Diarrhea Therapeutics Market Size, 2020-2031
1.3.3 China Traveler's Diarrhea Therapeutics Average Selling Price (ASP), 2020-2031
1.4 Share of China Traveler's Diarrhea Therapeutics Market with Respect to the Global Market
1.4.1 By Consumption Value, China Traveler's Diarrhea Therapeutics Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Traveler's Diarrhea Therapeutics Market Share in Global, 2020-2031
1.4.3 Traveler's Diarrhea Therapeutics Market Size: China VS Global, 2020-2031
1.5 Traveler's Diarrhea Therapeutics Market Dynamics
1.5.1 Traveler's Diarrhea Therapeutics Market Drivers
1.5.2 Traveler's Diarrhea Therapeutics Market Restraints
1.5.3 Traveler's Diarrhea Therapeutics Industry Trends
1.5.4 Traveler's Diarrhea Therapeutics Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Traveler's Diarrhea Therapeutics, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Traveler's Diarrhea Therapeutics, Global Market Share by Company, 2020-2025
2.3 Traveler's Diarrhea Therapeutics Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Traveler's Diarrhea Therapeutics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Traveler's Diarrhea Therapeutics Concentration Ratio
2.6 Global Traveler's Diarrhea Therapeutics Mergers & Acquisitions, Expansion Plans
2.7 Global Traveler's Diarrhea Therapeutics Manufacturers Product Type
2.8 Head Office and Traveler's Diarrhea Therapeutics Production Site of Key Manufacturer
2.9 Traveler's Diarrhea Therapeutics Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Traveler's Diarrhea Therapeutics, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Traveler's Diarrhea Therapeutics, China Market Share by Company, 2020-2025
3.3 China Traveler's Diarrhea Therapeutics Traveler's Diarrhea Therapeutics Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Traveler's Diarrhea Therapeutics Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Traveler's Diarrhea Therapeutics Capacity by Region
4.3 Global Traveler's Diarrhea Therapeutics Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Traveler's Diarrhea Therapeutics Production by Region, 2020-2031
4.5 Global Traveler's Diarrhea Therapeutics Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Traveler's Diarrhea Therapeutics Industry Chain
5.2 Traveler's Diarrhea Therapeutics Upstream Analysis
5.2.1 Traveler's Diarrhea Therapeutics Core Raw Materials
5.2.2 Main Manufacturers of Traveler's Diarrhea Therapeutics Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Traveler's Diarrhea Therapeutics Production Mode
5.6 Traveler's Diarrhea Therapeutics Procurement Model
5.7 Traveler's Diarrhea Therapeutics Industry Sales Model and Sales Channels
5.7.1 Traveler's Diarrhea Therapeutics Sales Model
5.7.2 Traveler's Diarrhea Therapeutics Typical Distributors

6 Sights by Type
6.1 Traveler's Diarrhea Therapeutics Classification by Type
6.1.1 Immunization
6.1.2 Non-antibiotic Agents
6.1.3 Antibiotics
6.1.4 Anti-Motility Agents
6.1.5 Others
6.2 by Type, Global Traveler's Diarrhea Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Traveler's Diarrhea Therapeutics Consumption Value, 2020-2031
6.4 by Type, Global Traveler's Diarrhea Therapeutics Sales Quantity, 2020-2031
6.5 by Type, Global Traveler's Diarrhea Therapeutics Average Selling Price (ASP), 2020-2031

7 Sights by Pathogen Type
7.1 Traveler's Diarrhea Therapeutics Classification by Pathogen Type
7.1.1 Bacterial TD
7.1.2 Viral TD
7.2 by Pathogen Type, Global Traveler's Diarrhea Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Pathogen Type, Global Traveler's Diarrhea Therapeutics Consumption Value, 2020-2031
7.4 by Pathogen Type, Global Traveler's Diarrhea Therapeutics Sales Quantity, 2020-2031
7.5 by Pathogen Type, Global Traveler's Diarrhea Therapeutics Average Selling Price (ASP), 2020-2031

8 Sights by Route of Administration
8.1 Traveler's Diarrhea Therapeutics Classification by Route of Administration
8.1.1 Oral Formulations
8.1.2 Injectable Formulations
8.1.3 Topical or Local Delivery
8.2 by Route of Administration, Global Traveler's Diarrhea Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Route of Administration, Global Traveler's Diarrhea Therapeutics Consumption Value, 2020-2031
8.4 by Route of Administration, Global Traveler's Diarrhea Therapeutics Sales Quantity, 2020-2031
8.5 by Route of Administration, Global Traveler's Diarrhea Therapeutics Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Traveler's Diarrhea Therapeutics Segment by Application
9.1.1 Adult Traveler's Diarrhea
9.1.2 Children Traveler's Diarrhea
9.2 by Application, Global Traveler's Diarrhea Therapeutics Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Traveler's Diarrhea Therapeutics Consumption Value, 2020-2031
9.4 by Application, Global Traveler's Diarrhea Therapeutics Sales Quantity, 2020-2031
9.5 by Application, Global Traveler's Diarrhea Therapeutics Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Traveler's Diarrhea Therapeutics Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Traveler's Diarrhea Therapeutics Consumption Value, 2020-2031
10.3 By Region, Global Traveler's Diarrhea Therapeutics Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Traveler's Diarrhea Therapeutics Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Traveler's Diarrhea Therapeutics Market Size Market Share
10.5 Europe
10.5.1 Europe Traveler's Diarrhea Therapeutics Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Traveler's Diarrhea Therapeutics Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Traveler's Diarrhea Therapeutics Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Traveler's Diarrhea Therapeutics Market Size Market Share
10.7 South America
10.7.1 South America Traveler's Diarrhea Therapeutics Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Traveler's Diarrhea Therapeutics Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Traveler's Diarrhea Therapeutics Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Traveler's Diarrhea Therapeutics Consumption Value, 2020-2031
11.3 By Country, Global Traveler's Diarrhea Therapeutics Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Traveler's Diarrhea Therapeutics Market Size, 2020-2031
11.4.2 by Type, United States Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Traveler's Diarrhea Therapeutics Market Size, 2020-2031
11.5.2 by Type, Europe Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Traveler's Diarrhea Therapeutics Market Size, 2020-2031
11.6.2 by Type, China Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Traveler's Diarrhea Therapeutics Market Size, 2020-2031
11.7.2 by Type, Japan Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Traveler's Diarrhea Therapeutics Market Size, 2020-2031
11.8.2 by Type, South Korea Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Traveler's Diarrhea Therapeutics Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Traveler's Diarrhea Therapeutics Market Size, 2020-2031
11.10.2 by Type, India Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Traveler's Diarrhea Therapeutics Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Traveler's Diarrhea Therapeutics Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Bausch Health
12.1.1 Bausch Health Company Information, Head Office, Market Area, and Industry Position
12.1.2 Bausch Health Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.1.3 Bausch Health Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Bausch Health Company Profile and Main Business
12.1.5 Bausch Health Recent Developments
12.2 P&G
12.2.1 P&G Company Information, Head Office, Market Area, and Industry Position
12.2.2 P&G Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.2.3 P&G Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 P&G Company Profile and Main Business
12.2.5 P&G Recent Developments
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
12.3.2 Johnson & Johnson Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Johnson & Johnson Company Profile and Main Business
12.3.5 Johnson & Johnson Recent Developments
12.4 Otsuka Pharma
12.4.1 Otsuka Pharma Company Information, Head Office, Market Area, and Industry Position
12.4.2 Otsuka Pharma Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Otsuka Pharma Company Profile and Main Business
12.4.5 Otsuka Pharma Recent Developments
12.5 Valneva
12.5.1 Valneva Company Information, Head Office, Market Area, and Industry Position
12.5.2 Valneva Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.5.3 Valneva Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Valneva Company Profile and Main Business
12.5.5 Valneva Recent Developments
12.6 Shanghai United Cell
12.6.1 Shanghai United Cell Company Information, Head Office, Market Area, and Industry Position
12.6.2 Shanghai United Cell Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 Shanghai United Cell Company Profile and Main Business
12.6.5 Shanghai United Cell Recent Developments
12.7 PaxVax
12.7.1 PaxVax Company Information, Head Office, Market Area, and Industry Position
12.7.2 PaxVax Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 PaxVax Company Profile and Main Business
12.7.5 PaxVax Recent Developments
12.8 Livzon
12.8.1 Livzon Company Information, Head Office, Market Area, and Industry Position
12.8.2 Livzon Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.8.3 Livzon Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Livzon Company Profile and Main Business
12.8.5 Livzon Recent Developments
12.9 Immuron
12.9.1 Immuron Company Information, Head Office, Market Area, and Industry Position
12.9.2 Immuron Traveler's Diarrhea Therapeutics Models, Specifications, and Application
12.9.3 Immuron Traveler's Diarrhea Therapeutics Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 Immuron Company Profile and Main Business
12.9.5 Immuron Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Traveler's Diarrhea Therapeutics should grow from US$ 1003 million in 2024 to US$ 1594 million by 2031, with a CAGR of 6.7% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Traveler's Diarrhea Therapeutics

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Traveler’s Diarrhea Therapeutics refer to a class of medications designed to prevent, alleviate, and treat acute diarrheal syndromes caused by foodborne or waterborne pathogens. This condition commonly affects international travelers, military personnel, business delegates, and humanitarian workers, with major causative agents including enterotoxigenic Escherichia coli (ETEC), Salmonella, Shigella, Vibrio, and Norovirus. Therapeutic options include antibiotics (such as fluoroquinolones and rifaximin), antisecretory agents, antidiarrheals (like loperamide), probiotics, and emerging vaccines or immune-modulatory therapies. The development of traveler’s diarrhea therapeutics is evolving from single-drug interventions to integrated, personalized, microbiota- and immunity-oriented strategies to improve efficacy and reduce antimicrobial resistance.In 2024, global Traveler’s Diarrhea Therapeutics production reached approximately 85.73 m units, with an average global market price of around US$ 11 perunit.The average gross profit margin of this product is 45%.

The increasing global mobility and resurgence of international tourism have driven steady growth in the traveler’s diarrhea therapeutics market. With the revival of the travel industry, business trips, and military deployments, this condition remains one of the most common travel-related health issues. Rising demand for fast-acting, safe, and low-resistance therapies has spurred the development of non-antibiotic treatments and microbiome-based interventions. Moreover, the growing emphasis on travel medicine and infection prevention by public health authorities worldwide is fostering research and innovation in therapeutics and vaccine development.

The industry faces key challenges such as escalating antibiotic resistance, increasingly stringent regulatory requirements, and poor patient compliance. Overreliance on antibacterial drugs has led to the proliferation of resistant strains, undermining traditional treatments. New drug candidates must meet higher safety and efficacy standards, prolonging development timelines. In addition, inadequate adherence or inappropriate use of medication among travelers contributes to suboptimal outcomes and higher complication risks. Regional variations in pathogen prevalence further complicate drug adaptability, creating uncertainty for companies expanding into global markets.

Downstream demand is becoming increasingly diversified. Clinicians are prioritizing combination therapies and microbiome modulation approaches that deliver rapid relief while minimizing antimicrobial resistance. Consumers show growing preference for convenient, portable, and safe over-the-counter (OTC) drugs and probiotic-based products. The expansion of digital health and telemedicine enables travelers to access personalized preventive and therapeutic guidance during trips. Industry players are transitioning from single-drug treatments to integrated “prevention–intervention–recovery” solutions aligned with holistic travel health management trends.

Upstream production of traveler’s diarrhea therapeutics primarily involves active pharmaceutical ingredients (APIs) and excipients, including antibacterial agents (e.g., rifaximin, azithromycin), antidiarrheal compounds, probiotic strains, and encapsulation carriers. Manufacturing requires high standards of purity, stability, and traceability, with increasingly rigorous quality control for microbial products. As the market shifts toward non-antibiotic and biologically derived therapies, new raw materials—such as natural extracts, probiotics, and synthetic peptides—are becoming R&D focal points. However, heavy reliance on international supply chains makes production costs and delivery timelines highly sensitive to geopolitical and trade policy fluctuations.

This report studies and analyses global Traveler's Diarrhea Therapeutics status and future trends, helps the client to determine the Traveler's Diarrhea Therapeutics market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Traveler's Diarrhea Therapeutics, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Traveler's Diarrhea Therapeutics market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Traveler's Diarrhea Therapeutics sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Traveler's Diarrhea Therapeutics sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Traveler's Diarrhea Therapeutics key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Traveler's Diarrhea Therapeutics key producing regions, capacity, production, and year over year growth
(6) Traveler's Diarrhea Therapeutics industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bausch Health
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron

Market segment by Type, covers
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others

Market segment by Pathogen Type, covers
Bacterial TD
Viral TD

Market segment by Route of Administration, covers
Oral Formulations
Injectable Formulations
Topical or Local Delivery

Market segment by Application, can be divided into
Adult Traveler's Diarrhea
Children Traveler's Diarrhea

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Traveler's Diarrhea Therapeutics product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Traveler's Diarrhea Therapeutics market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Traveler's Diarrhea Therapeutics market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Traveler's Diarrhea Therapeutics, percent & CAGR, 2020-2031
Chapter 5: Traveler's Diarrhea Therapeutics industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.